0001209191-21-069436.txt : 20211214
0001209191-21-069436.hdr.sgml : 20211214
20211214162855
ACCESSION NUMBER: 0001209191-21-069436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211210
FILED AS OF DATE: 20211214
DATE AS OF CHANGE: 20211214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cruse Michael
CENTRAL INDEX KEY: 0001854179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 211491292
MAIL ADDRESS:
STREET 1: C/O RENEO PHARMACEUTICALS, INC.
STREET 2: 12230 EL CAMINO REAL, SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-10
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001854179
Cruse Michael
C/O RENEO PHARMACEUTICALS, INC.
18575 JAMBOREE ROAD, SUITE 275-S
IRVINE
CA
92612
0
1
0
0
Senior VP-Corporate Operations
Common Stock
2021-12-10
4
A
0
25000
0.00
A
29100
D
Stock option (right to buy)
6.69
2021-12-10
4
A
0
75000
0.00
A
2031-12-09
Common Stock
75000
75000
D
Represents a restricted stock unit award.
Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021.
The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
/s/ Vineet R. Jindal, Attorney-in-Fact
2021-12-13